These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2872186)

  • 41. Sulfasalazine and its metabolites attenuate respiratory burst of leukocytes--a possible mechanism of anti-inflammatory effects.
    Suematsu M; Suzuki M; Miura S; Nagata H; Oshio C; Asakura H; Watanabe M; Tsuchiya M
    J Clin Lab Immunol; 1987 May; 23(1):31-3. PubMed ID: 2886669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I; Kumamoto T; Matsuda A; Kataoka M; Kokuba Y
    Arzneimittelforschung; 1998 Oct; 48(10):1007-11. PubMed ID: 9825118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of sulfasalazine on bovine endothelial cell proliferation and cell cycle phase distribution. Comparison with olsalazine, 5-aminosalicylic acid, and sulfapyridine.
    Sharon P; Drab EA; Linder JS; Weidman SW; Sabesin SM; Rubin DB
    J Lab Clin Med; 1992 Jan; 119(1):99-107. PubMed ID: 1345796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sulfasalazine and 5-ASA compounds.
    Allgayer H
    Gastroenterol Clin North Am; 1992 Sep; 21(3):643-58. PubMed ID: 1355468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensitization to epithelial antigens in chronic mucosal inflammatory disease. III. Serum factor modulates circulating and mucosal mononuclear-cell reactivity to epithelial cell-associated components of colon (ECAC-C).
    Dunkel G; Paul JW; Roche JK
    J Clin Immunol; 1987 Mar; 7(2):159-73. PubMed ID: 3571435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sulfasalazine inhibits the binding of TNF alpha to its receptor.
    Shanahan F; Niederlehner A; Carramanzana N; Anton P
    Immunopharmacology; 1990; 20(3):217-24. PubMed ID: 1981213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Compliance to therapy in patients on a maintenance dose of sulfasalazine.
    van Hees PA; van Tongeren JH
    J Clin Gastroenterol; 1982 Aug; 4(4):333-6. PubMed ID: 6126499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Azodisalicylate (azodisal sodium) causes intestinal secretion. Comparative study of the effect of azodisalicylate, sulfasalazine, 5-aminosalicylic acid and sulfapyridine on the water and electrolyte transfer and the morphology of the rat ileum and colon in vivo.
    Goerg KJ; Wanitschke R; Gabbert H; Breiling J; Franke M; Meyer zum Büschenfelde KH
    Digestion; 1987; 37(2):79-87. PubMed ID: 2887473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease.
    Schreiber S; MacDermott RP; Raedler A; Pinnau R; Bertovich MJ; Nash GS
    Gastroenterology; 1991 Oct; 101(4):1020-30. PubMed ID: 1889695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis.
    Xu J; Tam M; Samaei S; Lerouge S; Barralet J; Stevenson MM; Cerruti M
    Acta Biomater; 2017 Jan; 48():247-257. PubMed ID: 27769943
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon.
    Aparició-Pagés MN; Verspaget HW; Peña AS; Weterman IT; de Bruin PA; Mieremet-Ooms MA; van der Zon JM; van Tol EA; Lamers CB
    J Clin Lab Immunol; 1989 Jul; 29(3):119-24. PubMed ID: 2517428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.
    Astbury C; Taggart AJ; Juby L; Zebouni L; Bird HA
    Ann Rheum Dis; 1990 Aug; 49(8):587-90. PubMed ID: 1975737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of sulfasalazine on B cells.
    Imai F; Suzuki T; Ishibashi T; Dohi Y
    Clin Exp Rheumatol; 1991; 9(3):259-64. PubMed ID: 1678997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro immunomodulatory effects of sulfasalazine and its metabolites.
    Comer SS; Jasin HE
    J Rheumatol; 1988 Apr; 15(4):580-6. PubMed ID: 2899646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin 2 and interferon-gamma augment anticolon antibody dependent cellular cytotoxicity in ulcerative colitis.
    Hibi T; Ohara M; Watanabe M; Kanai T; Takaishi H; Hayashi A; Hosoda Y; Ogata H; Iwao Y; Aiso S
    Gut; 1993 Jun; 34(6):788-93. PubMed ID: 8100205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine.
    Liptay S; Bachem M; Häcker G; Adler G; Debatin KM; Schmid RM
    Br J Pharmacol; 1999 Dec; 128(7):1361-9. PubMed ID: 10602313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease.
    Rogler G; Meinel A; Lingauer A; Michl J; Zietz B; Gross V; Lang B; Andus T; Schölmerich J; Palitzsch KD
    Eur J Clin Invest; 1999 Apr; 29(4):330-6. PubMed ID: 10231345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease.
    Kusugami K; Matsuura T; West GA; Youngman KR; Rachmilewitz D; Fiocchi C
    Gastroenterology; 1991 Dec; 101(6):1594-605. PubMed ID: 1683326
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemolytic anemia in patients receiving sulfasalazine.
    Goodacre RL; Ali MA; Vanderlinden B; Hamilton JD; Castelli M; Seaton T
    Digestion; 1978; 17(6):503-8. PubMed ID: 30666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.